课题基金 / 基金详情

项目摘要

项目成果

William H Merigan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project summary Despite the current enthusiasm for optogenetic vision restoration, there is remarkably little direct evidence about whether it can reverse blindness in humans. The feasibility of optogenetics was first suggested by studies from many labs that showed restoration of neuronal visual responses and visually guided behaviors in previously blind mice or dogs. These studies have been very informative in exploring interventions to treat retinal diseases genetically identical to some human disorders. However, they have not addressed restoration in an animal model that closely matches human vision, nor have they examined the perceptual quality of the restored vision. In the studies proposed here, we will address these two issues, first by using macaque monkeys in all studies, the animal model that most resembles humans in visual structure and function, and second by examining the range of visual perceptual abilities made possible by optogenetics. We will use a recently developed in-vivo physiology method to study vision restoration at the level of individual retinal cells in macaque monkeys. This approach will be used in the first aim to examine at a cellular level the spatial, temporal and sensitivity responses of macaque retinal neurons produced by optogenetic restoration. In the second aim we will use controlled fixation psychophysical testing of macaques to examine the range of visual capabilities provided by channelrhodopsin restoration, something that has never been studied. Finally, we will examine the duration of optogenetic restoration, measuring any long-term decrease in function or practice-related improvement in visual function.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Restoring vision at the fovea.
恢复中央凹的视力。
DOI: 10.1016/j.cobeha.2019.10.003
发表时间: 2019-12
期刊: Current opinion in behavioral sciences
影响因子: 5
作者: [McGregor JE]
通讯作者: McGregor JE
Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
抗体中和构成玻璃体内腺相关病毒载体基因递送至非人类灵长类动物的障碍。
DOI: 10.1038/gt.2014.115
发表时间: 2015-02
期刊: GENE THERAPY
影响因子: 5.1
作者: [Kotterman, M. A., Yin, L., Strazzeri, J. M., Flannery, J. G., Merigan, W. H., Schaffer, D. V.]
通讯作者: Schaffer, D. V.
Engineering the Eye IV Restoring Vision
  • 批准号:
    8785777
  • 项目类别:
  • 资助金额:
    $1.84万
  • 财政年份:
    2014
  • 负责人:
    William H Merigan
  • 依托单位:
Physiological and perceptual examination of vision restoration
  • 批准号:
    10357890
  • 项目类别:
  • 资助金额:
    $70.57万
  • 财政年份:
    2011
  • 负责人:
    William H Merigan
  • 依托单位:
Functional Imaging of Ganglion Cells in the Living Mammalian Eye
  • 批准号:
    8021616
  • 项目类别:
  • 资助金额:
    $68.15万
  • 财政年份:
    2011
  • 负责人:
    William H Merigan
  • 依托单位:
Functional Imaging of Ganglion Cells in the Living Mammalian Eye
  • 批准号:
    8435519
  • 项目类别:
  • 资助金额:
    $59.13万
  • 财政年份:
    2011
  • 负责人:
    William H Merigan
  • 依托单位:
国内基金
海外基金
greenwashing behavior in China:Basedon an integrated view of reconfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位:
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位: